(AVDE) Avantis International Equity - Overview
Etf: Equity, Derivative, Currency, Swap, Futures
Dividends
| Dividend Yield | 2.88% |
| Yield on Cost 5y | 4.27% |
| Yield CAGR 5y | 8.90% |
| Payout Consistency | 92.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.7% |
| Relative Tail Risk | 1.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.00 |
| Alpha | 30.43 |
| Character TTM | |
|---|---|
| Beta | 0.633 |
| Beta Downside | 0.605 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.46% |
| CAGR/Max DD | 1.47 |
Description: AVDE Avantis International Equity January 07, 2026
The Avantis® International Equity ETF (NYSE ARCA: AVDE) targets a broad universe of non-U.S. equities, spanning multiple countries, sectors, and industry groups, and may include firms of any market-cap size. In normal market conditions the fund commits at least 80 % of its net assets to equity securities, while also employing derivatives such as futures, currency forwards, and swaps to manage exposure and enhance returns.
Based on the most recent fund fact sheet (as of Q4 2025), AVDE carries an expense ratio of 0.25 % and manages roughly $2.1 billion in assets, with its largest regional exposure in Europe (≈45 % of assets) and a secondary tilt toward Asia-Pacific (≈30 %). Top holdings include multinational firms like Nestlé, Roche, and Samsung Electronics, giving the ETF a notable weighting toward consumer staples, healthcare, and technology-sectors that have historically outperformed in low-growth environments. A key macro driver for AVDE is the Eurozone’s real-GDP growth trajectory, which currently averages 0.8 % YoY, influencing the performance of its European constituents; likewise, currency fluctuations between the USD and major foreign currencies can materially affect net returns.
For a deeper dive into AVDE’s risk-adjusted performance metrics and how its sector bets compare to global benchmarks, you might explore the analytics on ValueRay.
What is the price of AVDE shares?
Over the past week, the price has changed by +2.29%, over one month by +5.57%, over three months by +13.99% and over the past year by +41.11%.
Is AVDE a buy, sell or hold?
What are the forecasts/targets for the AVDE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 108.5 | 22.1% |
AVDE Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 13.14b USD (13.14b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 13.14b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 13.14b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.25% (E(13.14b)/V(13.14b) * Re(8.25%) + (debt-free company))
Discount Rate = 8.25% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)